Bravecto lasts nearly 3x longer than monthlies
12 week protection

Life is simpler with Bravecto.3,4

One dose of Bravecto consistently eliminates flea and tick infestations for 12 weeks*.

Discover the Bravecto difference

#1

Preferred by vets and pet owners

Bravecto is the no. 1 prescription parasite product in the UK.¹ Up to 92% of pet owners prefer 12-weekly* Bravecto.3,4

#1

Kills fast and lasts²

Bravecto starts killing fleas within 2 hours†5, and ticks within 4 hours†6 and continues to work for 12 weeks* with a single dose.

#1

Convenient dosing - chew or spot-on

Bravecto is the only product available as a tasty chew⁷ and spot-on for dogs, and spot-on for cats with or without a wormer.

#1

Established safety record⁺⁺

Tried and trusted around the world, with over 200 million doses sold across 90 countries.

DOGS
BRAVECTO® Chew for dogs
DOGS
BRAVECTO® Spot-on for dogs
CATS
BRAVECTO® Spot-on for cats
CATS
BRAVECTO® Plus for cats
References:

1. Number 1 selling Companion Animal Parasiticide product in the UK prescription veterinary market. Kynetec VetTrak MAT, March 2022. 2. Summary of Product Characteristics (Bravecto Dog Chew, Bravecto Dog Spot-on, Bravecto Cat Spot-on and Bravecto Plus). 3. Lavan R et al. (2021). Flea and tick treatment satisfaction, preference, and adherence reported by cat owners in the US, UK, or France who treated their cats with transdermal fluralaner. Open Veterinary Journal Vol. 11(3): 458-467. 4. Lavan R et al. (2020). Flea and tick treatment satisfaction, preference, and adherence of dog owners in the United States, United Kingdom, and Australia who treated their dog with fluralaner. Open Veterinary Journal Vol. 10(2): 135-143. 5. Taenzler et al. (2014). Parasites & Vectors 7:567. 6. Wengenmayer et al. (2014). Parasites & Vectors 7:525. 7. Meadows et al. (2014) Parasites & Vectors 7:375.

*Bravecto Spot-on has 12-week duration of efficacy against flea and tick species indicated in the SPC. Bravecto Chewable Tablets include an 8-week immediate and persistent killing activity against Rhipicephalus sanguineus. For further information refer to the relevant SPC.

†Statements on speed of kill and / or percentage of kill reflect data observed in dog studies.

++Bravecto has been extensively tested with ongoing clinical research and monitoring. Bravecto for dogs is licensed for puppies over 8 weeks old, with minimum weight at least 2 kg along with breeding, pregnant and lactating dogs. Bravecto Spot-On for cats and Bravecto Plus are safe to use on kittens from 9 weeks of age, with minimum weight at least 1.2 kg.

Bravecto® Spot-on for Cats and Bravecto® Chewable Tablets and Spot-on for Dogs contain fluralaner. POM-V.
Bravecto® Plus Spot-on for Cats contains fluralaner and moxidectin. POM-V.
Further information is available from the SPC, datasheet or package leaflet.
Advice should be sought from the medicine prescriber.
Prescription decisions are for the person issuing the prescription alone.
Use Medicines Responsibly.

MSD Animal Health UK Limited, Walton Manor, Walton, Milton Keynes, MK7 7AJ, UK
Registered in England & Wales no. 946942

I confirm that I am an Animal Health Professional working in the United Kingdom or that I am a pet owner who has been prescribed Bravecto® for my pet.